Our protocols meet the requirements of the agencies recognized by health surveillance of drugs (FDA, EMA), related institutions (ICH, OECD, NCI, WHO), as well as ANVISA and its “Guide to Non Clinical Studies Required for Drug Development” (2013). Non-clinical studies offered by TECAM Laboratories include: single dose toxicity studies (acute), repeated dose toxicity, genotoxicity, local tolerance and studies related to pharmacological and toxicokinetics properties. Other studies for safety evaluation may be requested.
*Please see the website for the accredited tests.
“Guidelines to Non Clinical Studies Required for Drug Development” (ANVISA, 2013).